ArticleMolecular therapy. Nucleic acids2024

Selective targeting of chemically modified miR-34a to prostate cancer using a small molecule ligand and an endosomal escape agent.

Ahmed M Abdelaal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.